Skip to main content
    O

    OneMedNet Corp. (ONMD)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $4.75
    +0.04 (+0.85%)

    Market Cap: $27.43M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-0.04N/AN/ABeat-157.1%
    Mar 26
    Reported May 15
    		$-0.44N/AN/ABeat-639.0%
    Dec 25
    Reported Mar 30
    		$-0.60N/AN/ABeat+28.8%
    Sep 25
    Reported Nov 14
    		$-0.01N/AN/ABeat+98.6%
    Jun 25
    Reported Aug 13
    		$0.07N/AN/ABeat+104.7%
    Mar 25
    Reported Apr 15
    		$-0.06N/AN/ABeat+93.3%
    Dec 24
    Reported Dec 31
    		$-0.85N/AN/ABeat+98.2%
    Sep 24
    Reported Dec 5
    		$-0.74N/AN/ABeat+36.7%
    Jun 24
    Reported Jun 30
    		$-1.50N/AN/ABeat-21947.1%
    Mar 24
    Reported Jun 28
    		$-0.89N/AN/ABeat+95.4%
    Dec 23
    Reported Mar 29
    		$-46.45N/AN/ABeat-21015.7%
    Sep 23
    Reported Dec 29
    		$-1.17N/AN/ABeat-11555.0%
    Jun 23
    Reported Aug 14
    		$-0.01N/AN/ABeat-111.3%
    Mar 23
    Reported May 19
    		$-19.40N/AN/ABeat-64580.3%
    Dec 22
    Reported Mar 30
    		$-0.22$0.00N/AMiss+29.1%
    Sep 22
    Reported Nov 18
    		$-0.01$0.00N/AMiss-111.1%
    Jun 22
    Reported Aug 15
    		$0.06$0.00N/ABeat-80.6%
    Mar 22
    Reported May 16
    		$-0.03$0.00N/AMiss-
    Dec 21
    Reported Dec 31
    		$-0.31N/AN/ABeat-
    Sep 21
    Reported Nov 15
    		$0.09$0.00N/ABeat-
    Jun 21
    Reported Aug 16
    		$0.31$0.00N/ABeat-
    Mar 21
    Reported Jun 21
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.43EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-774.00%
    ROE0.00%ROIC236.44%
    Financial Health
    Debt/Equity-0.20xInterest Coverage-113.93x
    Current Ratio0.28xQuick Ratio0.28x
    Trading Statistics
    Beta1.15Avg Volume309.24K
    52-Week High$28.2052-Week Low$3.61

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.69
    SMA 20$5.51
    SMA 50$6.03
    SMA 200$7.59
    EMA 10$4.77
    EMA 20$5.22
    EMA 50$5.87
    EMA 200$7.52

    MACD

    Line: -0.53Signal: -0.44Hist: -0.09

    ADX

    ADX: 46.2+DI: 8.7-DI: 3.9

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down44.0
    PSAR$1.83

    Bollinger Bands

    Upper Band$7.51
    Lower Band$3.51
    %B Position7265%(Upper)
    Band Width0.31

    RSI (14-Day)

    Neutral
    41.3

    Momentum Oscillators

    Stoch %K67.9
    Stoch %D64.0
    Williams %R-27.7
    ROC (10d)-13.6%
    Momentum-0.75
    CCI (20d)32.3
    MFI (14d)51.9

    Volatility Measures

    ATR (14d)$2.53(53.2%)
    StdDev (20d)1.00
    Hist Vol133.8%(High)

    Volume Flow

    VWAP$4.65
    OBV1.4B
    AD Line73.8B
    CMF (20d)141.373

    Volume Metrics

    Avg Vol (20d)332.1K
    Vol Ratio0.1x(Low)
    VWMA (20d)$6.47

    Pivot Points

    R3$5.50
    R2$5.10
    R1$4.91
    Pivot Point$4.51
    S1$4.32
    S2$3.92
    S3$3.73

    Advanced Oscillators

    TSI-24.48
    Ultimate Osc63.9
    KST-233.61

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$292,000$96,000$890,000$177,000$155,000$137,000$26,000$142,000$227,000$248,000$322,000$326,000
    Cost of Revenue$857,000$476,000$706,000$399,000$396,000$361,000$52,000$226,000$329,000$317,000$338,000$293,000
    Gross Profit$-565,000$-380,000$184,000$-222,000$-241,000$-224,000$-26,000$-84,000$-102,000$-69,000$-16,000$33,000
    Operating Expenses$1.70M$2.17M$3.33M$2.01M$1.82M$2.00M$2.69M$2.25M$2.35M$2.03M$1.87M$1.96M
    R&D$324,000$311,000$462,000$323,000$382,000$348,000$341,000$298,000$383,000$445,000$499,000$405,000
    SG&A$981,000$1.48M$2.45M$1.39M$1.18M$1.36M$2.14M$1.81M$1.72M$1.36M$1.07M$1.31M
    Operating Income$-2,261,000$-2,552,000$-3,145,000$-2,235,000$-2,063,000$-2,224,000$-2,714,000$-2,336,000$-2,454,000$-2,101,000$-1,886,000$-1,927,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$9,000$10,000$8,000$47,000$22,000$31,000$28,000$36,000$41,000$42,000$11,000$0
    Income Before Tax$-2,172,000$-2,453,000$-3,139,000$-741,000$2.98M$-1,902,000$-2,371,000$-2,058,000$-3,589,000$-2,109,000$-2,495,000$-13,840,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,172,000$-2,453,000$-3,140,000$-741,000$2.98M$-1,902,000$-2,373,000$-2,058,000$-3,589,000$-2,109,000$-2,513,000$-13,840,000
    EBITDA$-2,158,000$-2,432,000$-3,122,000$-684,000$3.04M$-1,859,000$-2,317,000$-2,012,000$-3,538,000$-2,056,000$-2,475,000$-13,834,000
    EBIT$-2,163,000$-2,443,000$-3,131,000$-694,000$3.00M$-1,871,000$-2,343,000$-2,022,000$-3,548,000$-2,067,000$-2,484,000$-13,840,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ONMD

    News

    CEO Aaron Green received a 65,000-share stock grant and sold shares for taxes at OneMedNet (ONMD).

    OneMedNet CEO Aaron Green received a grant of 65,000 restricted stock units (RSUs) on July 6, 2026. He subsequently sold 6,667 common shares across two transactions in September 2026 to cover tax obligations arising from...

    Stock Titan•10/10/26•Somewhat-Bearish

    OneMedNet CEO Aaron Green Reports RSU Award and Subsequent Share Sales Post-Reverse Split

    OneMedNet CEO Aaron Green received 65,000 Restricted Stock Units (RSUs) on July 6, 2026. He subsequently sold 6,667 shares in two separate transactions on September 22 and 24, 2026...

    Kalkine Media•10/9/26•Neutral

    Form 4 Onemednet Corp Class A For: 30 September By Investing.com

    This article from Investing.com reports on a Form 4 filing for Onemednet Corp Class A, detailing transactions for September 30. It provides no further specifics beyond the filing's existence and date. The article is very...

    Investing.com Nigeria•9/30/26•Neutral

    Form 4 Onemednet Corp Class A For: 30 September By Investing.com

    This article announces the filing of Form 4 for Onemednet Corp Class A for the period ending September 30. The brief notice from Investing.com indicates that this is a standard regulatory filing. The content focuses...

    Investing.com Canada•9/30/26•Neutral

    OneMedNet Corp Class A Financial Disclosures & SEC Filings

    This page provides access to OneMedNet Corp's (ONMD) financial disclosures and SEC filings, including Forms 10-K, 10-Q, and 8-K. The listed documents detail the company's financial performance, operational updates...

    TradingView•9/18/26•Somewhat-Bearish

    ONMD Valuation and Fair Value

    P/E
    -0.4x
    P/B
    -7.8x
    See GNG's fair value

    ONMD Profitability: Margins, ROIC and FCF

    Gross margin
    -67.6%
    Operating margin
    -774.0%
    Net margin
    0.0%
    ROIC
    236.4%
    ROE
    0.0%
    FCF margin
    -460.8%

    ONMD Competitors

    CompanyTicker
    Transcode Therapeutics IncRNAZ
    Plus Therapeutics IncPSTV
    MIRA Pharmaceuticals, Inc. Common StockMIRA
    India Globalization Capital IncIGC
    Evoke Pharma IncEVOK
    SRx Health Solutions Inc.SRXH
    Sangamo Therapeutics IncSGMO
    PetMed Express IncPETS

    Sector: Healthcare

    ONMD Bull Case vs Bear Case

    Bull case

    • ONMD earns a 236.4% return on invested capital.
    • ONMD grew quarterly revenue 88.4% year over year.

    ONMD Earnings: Beat Rate and Next Report

    Beat rate
    3 of 7 quarters (42.9%)

    Frequently Asked Questions About ONMD

    Does ONMD pay dividends?

    OneMedNet Corp. (ONMD) does not currently pay a regular dividend.

    What is ONMD's market cap?

    OneMedNet Corp. (ONMD) has a market capitalization of $27.43M with a current stock price of $4.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In